Correlation Between Lantern Pharma and Regulus Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lantern Pharma and Regulus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantern Pharma and Regulus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lantern Pharma and Regulus Therapeutics, you can compare the effects of market volatilities on Lantern Pharma and Regulus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantern Pharma with a short position of Regulus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantern Pharma and Regulus Therapeutics.

Diversification Opportunities for Lantern Pharma and Regulus Therapeutics

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Lantern and Regulus is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Lantern Pharma and Regulus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regulus Therapeutics and Lantern Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantern Pharma are associated (or correlated) with Regulus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regulus Therapeutics has no effect on the direction of Lantern Pharma i.e., Lantern Pharma and Regulus Therapeutics go up and down completely randomly.

Pair Corralation between Lantern Pharma and Regulus Therapeutics

Given the investment horizon of 90 days Lantern Pharma is expected to under-perform the Regulus Therapeutics. In addition to that, Lantern Pharma is 1.27 times more volatile than Regulus Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Regulus Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest  149.00  in Regulus Therapeutics on September 2, 2024 and sell it today you would earn a total of  12.00  from holding Regulus Therapeutics or generate 8.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Lantern Pharma  vs.  Regulus Therapeutics

 Performance 
       Timeline  
Lantern Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lantern Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Regulus Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Regulus Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent essential indicators, Regulus Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Lantern Pharma and Regulus Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lantern Pharma and Regulus Therapeutics

The main advantage of trading using opposite Lantern Pharma and Regulus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantern Pharma position performs unexpectedly, Regulus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regulus Therapeutics will offset losses from the drop in Regulus Therapeutics' long position.
The idea behind Lantern Pharma and Regulus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum